A JZP341 Study in Adult Participants With Advanced or Metastatic Solid Tumors

BMS-188797 in Treating Patients With Advanced Solid Tumors That Have Not Responded to Previous Treatment

NCT00005611 ·Status: UNKNOWN ·Phase: PHASE1

Testing How the Body Responds to the Drug CBX-12 in Patients With Advanced Solid Cancers

NCT05691517 ·Status: RECRUITING ·Phase: PHASE1

A Study of Mipasetamab Uzoptirine (ADCT-601) in Participants With Solid Tumors

NCT05389462 ·Status: TERMINATED ·Phase: PHASE1

A Study Evaluating the Safety and Pharmacokinetics of Orally Administered SM08502 in Subjects With Advanced Solid Tumors

NCT03355066 ·Status: TERMINATED ·Phase: PHASE1

Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment

NCT00005639 ·Status: COMPLETED ·Phase: PHASE1

Oral SAR245408 (XL147) and Oral MSC1936369B in Patients With Locally Advanced or Metastatic Solid Tumors

NCT01357330 ·Status: COMPLETED ·Phase: PHASE1

A Pharmacokinetic and Pharmacodynamic Study of DZ-002 in Patients With Advanced Solid Malignancies or Lymphoma

NCT04970992 ·Status: COMPLETED ·Phase: PHASE1

Testing the Safety of CB-5339 in Patients With Cancer

NCT04372641 ·Status: WITHDRAWN ·Phase: PHASE1

A Study of JNJ-70218902 in Participants With Advanced Stage Solid Tumors

NCT04397276 ·Status: COMPLETED ·Phase: PHASE1

A Study of PF-07260437 in Advanced or Metastatic Solid Tumors

NCT05067972 ·Status: TERMINATED ·Phase: PHASE1

Phase 1, Safety and Tolerability Study of XmAb541 in Advanced Solid Tumors

NCT06276491 ·Status: RECRUITING ·Phase: PHASE1

A Study of the Safety and Pharmacokinetics of GDC-0152, Administered Intravenously to Patients With Locally Advanced or Metastatic Malignancies

NCT00977067 ·Status: TERMINATED ·Phase: PHASE1

A Phase 1 Study Evaluating CB-5083 in Subjects With Advanced Solid Tumors

NCT02243917 ·Status: TERMINATED ·Phase: PHASE1

A Study to Evaluate the Safety, Pharmacokinetics, and Activity of RO7566802 as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Solid Tumors

NCT06031441 ·Status: RECRUITING ·Phase: PHASE1

A Study of Orally Administered JBI-802, an LSD1/HDAC6 Inhibitor, in Patients With Advanced Solid Tumors

NCT05268666 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Study of ZL-1211 in Patients With Advanced Solid Tumor

NCT05065710 ·Status: COMPLETED ·Phase: PHASE1

Safety, Pharmacokinetics and Clinical Activity of AZD0171 in Combination With Durvalumab and Chemotherapy in Locally Advanced or Metastatic Solid Tumours

NCT04999969 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Dasatinib in Treating Patients With Solid Tumors or Lymphomas That Are Metastatic or Cannot Be Removed By Surgery

NCT00608361 ·Status: COMPLETED ·Phase: PHASE1

JYB1907 in Subjects With Advanced Solid Tumors

NCT05821595 ·Status: UNKNOWN ·Phase: PHASE1

A First-in-Human, Phase 1 Study of JAB-3312 in Adult Patients With Advanced Solid Tumors

NCT04045496 ·Status: COMPLETED ·Phase: PHASE1

A Study to Evaluate the Activity, Safety and Tolerability of ZX-101A in Advanced Solid Tumors

NCT05258266 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2

A Phase I Study of STA-5312 in Subjects With Advanced or Metastatic Solid Tumors

NCT00276913 ·Status: COMPLETED ·Phase: PHASE1

IPH5401 (Anti-C5aR) in Combination With Durvalumab in Patients With Advanced Solid Tumors

NCT03665129 ·Status: TERMINATED ·Phase: PHASE1

A Study of LY3039478 in Participants With Advanced or Metastatic Solid Tumors

NCT02784795 ·Status: TERMINATED ·Phase: PHASE1

Study to Evaluate JCXH-211 as Monotherapy in Patients With Malignant Solid Tumors

NCT05539157 ·Status: UNKNOWN ·Phase: PHASE1